Metaphyseal Distal Radius Fractures
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jul 2, 2010
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
Because an increasing number of elderly patient, the number of osteoporotic fractures, among which the fractures of the lower extremity of the radius (16 % of fractures seen in emergencies) is going to increase. Several surgical techniques exist of which in particular locking plates and intrafocal pinning.
The availability of new materials (locking plates with angular stability) seems to reduce the risks of osteosynthesis failure and seems to give more constant results: hawever, the price to pay is a more invasive technique and a superior cost. The rehabilitation seems also faster, allowin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - metaphyseal inferior radius fractures (AO classification 23A2, 23A3, 23C1, 23C2)
- • age 60 years or older
- Exclusion Criteria:
- • open fracture
- • fractures AO classification: 23A1, 23C3, 23B1, 23B2, 23B3
- • polytraumatized patient
- • fractures older than 15 days
- • infection of the operating site
- • previous osseous disease
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Stéphane DESCAMPS, MD
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials